Supreme Court decides the patent suit of Lyrica on 14th

The final decision of the patent suit for the use patent of the Lyrica(Pfizer), a large-scale painkiller, will be made on the 14^th.

The Supreme Court will announce the decision on the action of nullity of the Lyrica’s use patent, filed by CJ HealthCare and Samjin Pharm, on the 14^th.

The fight among Pfizer having Lyrica of KRW 30 billion and generic companies has been processed with the subjec...